MILLENNIUM MANAGEMENT LLC 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-09 4:18 pm Sale |
2024-09-30 | 13G | Aclaris Therapeutics, Inc. ACRS |
MILLENNIUM MANAGEMENT LLC | 3,005,598 4.200% |
-764,328 (-20.27%) |
Filing |
| 2024-02-14 4:13 pm Purchase |
2024-02-05 | 13G | Aclaris Therapeutics, Inc. ACRS |
MILLENNIUM MANAGEMENT LLC | 3,769,926 5.300% |
290,565 (+8.35%) |
Filing |
| 2024-02-01 4:15 pm Sale |
2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
MILLENNIUM MANAGEMENT LLC | 3,479,361 4.900% |
-108,753 (-3.03%) |
Filing |
| 2023-12-11 4:25 pm Purchase |
2023-12-07 | 13G | Aclaris Therapeutics, Inc. ACRS |
MILLENNIUM MANAGEMENT LLC | 3,588,114 5.100% |
3,588,114 (New Position) |
Filing |